{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:49:14Z","timestamp":1794620954095,"version":"4.9.1"},"reference-count":30,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Trauma-induced coagulopathy describes a complex set of coagulation changes affecting severely injured patients. The thrombomodulin-protein C axis is believed to be central to the evolution of trauma-induced coagulopathy. Soluble thrombomodulin (sTM) levels are elevated after injury. Our objectives were to explore whether sTM (at concentrations found in patients after injury) plays an important role in trauma-induced coagulopathy, and specifically to evaluate the effects of sTM and activated protein C (APC) on thrombin generation (TG) and clot lysis time (CLT). Plasma from healthy volunteers was spiked with rising concentrations of sTM and APC and the effects on TG and CLT were analyzed. Plasma samples from a cohort of trauma patients were evaluated using TG and CLT, and results correlated to clinical parameters and factor VIII, factor V, APC, sTM and fibrinolytic measures. Increasing sTM concentrations in volunteer plasma led to reductions in endogenous thrombin potential and prolongation of 50% CLT, in a dose-dependent manner. No effect on TG or CLT was seen with rising APC concentrations. In 91 trauma patients, higher sTM values were associated with greater, rather than reduced, endogenous thrombin potential (median 1,483 vs. 1,681 nM\/min) and longer 50% CLT (41.9 vs. 54.0 mins). In conclusion, sTM concentrations, across ranges found after trauma, affect both TG and 50% CLT, unlike APC. Despite increased circulating sTM levels, the overriding dynamic coagulation effects seen after injury are: (i) accelerated TG and (ii) increased rates of fibrinolysis. We found no evidence for sTM as the major determinant of the coagulation changes seen in early trauma-induced coagulopathy.<\/jats:p>","DOI":"10.3324\/haematol.2024.285951","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T15:40:07Z","timestamp":1725550807000},"page":"414-424","source":"Crossref","is-referenced-by-count":2,"title":["Impact of soluble thrombomodulin and activated protein C on dynamic hemostatic function in trauma: a focus on thrombin generation and clot lysis"],"prefix":"10.3324","volume":"110","author":[{"given":"Nicola S.","family":"Curry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeries","family":"Abu-Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gael B.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Laffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"72145","doi-asserted-by":"crossref","unstructured":"Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003; 54(6):1127-1130.","DOI":"10.1097\/01.TA.0000069184.82147.06"},{"key":"72146","doi-asserted-by":"crossref","unstructured":"MacLeod JBA, Lynn M, McKenney MG, Cohn SM, Murtha M. Early coagulopathy predicts mortality in trauma. J Trauma. 2003; 55(1):39-44.","DOI":"10.1097\/01.TA.0000075338.21177.EF"},{"key":"72147","doi-asserted-by":"crossref","unstructured":"Davenport R, Manson J, De\u2019Ath H. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med. 2011; 39(12):2652-2658.","DOI":"10.1097\/CCM.0b013e3182281af5"},{"key":"72148","doi-asserted-by":"crossref","unstructured":"Brohi K, Cohen MJ, Ganter MT. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008; 64(5):1211-1217.","DOI":"10.1097\/TA.0b013e318169cd3c"},{"key":"72149","doi-asserted-by":"crossref","unstructured":"Davenport RA, Guerreiro M, Frith D. Activated protein C drives the hyperfibrinolysis of acute traumatic coagulopathy. Anesthesiology. 2017; 126(1):115-127.","DOI":"10.1097\/ALN.0000000000001428"},{"key":"72150","doi-asserted-by":"crossref","unstructured":"Raza I, Davenport R, Rourke C. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013; 11(2):307-314.","DOI":"10.1111\/jth.12078"},{"key":"72151","doi-asserted-by":"crossref","unstructured":"Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet J-F. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?. Ann Surg. 2007; 245(5):812-818.","DOI":"10.1097\/01.sla.0000256862.79374.31"},{"key":"72152","doi-asserted-by":"crossref","unstructured":"Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann Surg. 2011; 254(2):194-200.","DOI":"10.1097\/SLA.0b013e318226113d"},{"key":"72153","doi-asserted-by":"crossref","unstructured":"Gando S, Wada H, Thachil J. Differentiating disseminated intravascular coagulation (DIC) with the fibrinolytic phenotype from coagulopathy of trauma and acute coagulopathy of trauma-shock (COT\/ACOTS). J Thromb Haemost. 2013; 11(5):826-835.","DOI":"10.1111\/jth.12190"},{"key":"72154","doi-asserted-by":"crossref","unstructured":"Esmon CT. The protein C pathway. Chest. 2003; 124(3 Suppl):26S-32S.","DOI":"10.1378\/chest.124.3_suppl.26S"},{"key":"72155","doi-asserted-by":"crossref","unstructured":"Sillen M, DeClercq PJ. Thrombin activatable fibrinolysis inhibitor (TAFI): an updated narrative review. Int J Mol Sci. 2021; 22(7):3670.","DOI":"10.3390\/ijms22073670"},{"key":"72156","doi-asserted-by":"crossref","unstructured":"Westbury SK, Whyte CS, Stephens J, NIHR BioResource. A new pedigree with thrombomodulin-associated coagulopathy in which delayed fibrinolysis is partially attenuated by coinherited TAFI deficiency. J Thromb Haemost. 2020; 18(9):2209-2214.","DOI":"10.1111\/jth.14990"},{"key":"72157","doi-asserted-by":"crossref","unstructured":"Dargaud Y, Scoazec JY, Wielders SJ. Characterization of an autosomal dominant bleeding disorder caused by a thrombomodulin mutation. Blood. 2015; 125(9):1497-1501.","DOI":"10.1182\/blood-2014-10-604553"},{"key":"72158","doi-asserted-by":"crossref","unstructured":"Osada M, Maruyama K, Kokame K. A novel homozygous variant of the thrombomodulin gene causes a hereditary bleeding disorder. Blood Adv. 2021; 5(19):3830-3838.","DOI":"10.1182\/bloodadvances.2020003814"},{"key":"72159","doi-asserted-by":"crossref","unstructured":"Morrow GB, Beavis J, Harper S, Bignell P, Laffan MA, Curry N. Characterisation of a novel thrombomodulin c.1487delC,p. (Pro496Argfs*10) variant and evaluation of therapeutic strategies to manage the rare bleeding phenotype. Thromb Res. 2021; 197:100-108.","DOI":"10.1016\/j.thromres.2020.11.002"},{"key":"72160","doi-asserted-by":"crossref","unstructured":"Hemker HC, Giesen P, Al Dieri R. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002; 32(5-6):249-253.","DOI":"10.1159\/000073575"},{"key":"72161","unstructured":"Longstaff C. Analysis of clotting and lysis data. 2024. Publisher Full Text|"},{"key":"72162","doi-asserted-by":"crossref","unstructured":"Altman DG. Practical Statistics for Medical Research. 1st ed. London (UK). 1990.","DOI":"10.1201\/9780429258589"},{"key":"72163","doi-asserted-by":"crossref","unstructured":"Hagemo JS, N\u00e6ss PA, Johansson P. Evaluation of TEG(\u00ae) and RoTEM(\u00ae) inter-changeability in trauma patients. Injury. 2013; 44(5):600-605.","DOI":"10.1016\/j.injury.2012.11.016"},{"key":"72164","doi-asserted-by":"crossref","unstructured":"Dielis AW, Castoldi E, Spronk HM. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost. 2008; 6(1):125-131.","DOI":"10.1111\/j.1538-7836.2007.02824.x"},{"key":"72165","doi-asserted-by":"crossref","unstructured":"Burley K, Whyte CS, Westbury SK. Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy. Blood. 2016; 128(14):1879-1883.","DOI":"10.1182\/blood-2016-05-716092"},{"key":"72166","doi-asserted-by":"crossref","unstructured":"Miszta A, Kopec AK, Pant A. A high-fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice. Blood. 2020; 135(19):1704-1717.","DOI":"10.1182\/blood.2019004267"},{"key":"72167","doi-asserted-by":"crossref","unstructured":"Campbell JE, Meledeo MA, Cap AP. Comparative response of platelet FV and plasma FV to activated protein C and relevance to a model of acute traumatic coagulopathy. PLoS One. 2014; 9(6):e99181.","DOI":"10.1371\/journal.pone.0099181"},{"key":"72168","doi-asserted-by":"crossref","unstructured":"Allen GA, Wolberg AS, Oliver JA, Hoffman M, Roberts HR, Monroe DM. Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost. 2004; 2(3):402-413.","DOI":"10.1111\/j.1538-7933.2003.00617.x"},{"key":"72169","doi-asserted-by":"crossref","unstructured":"Park MS, Xue A, Spears GM. Thrombin generation and procoagulant microparticle profiles after acute trauma: a prospective cohort study. J Trauma Acute Care Surg. 2015; 79(5):726-731.","DOI":"10.1097\/TA.0000000000000839"},{"key":"72170","doi-asserted-by":"crossref","unstructured":"CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011; 377(9771):1096-1101.","DOI":"10.1016\/S0140-6736(11)60278-X"},{"key":"72171","doi-asserted-by":"crossref","unstructured":"Wu C, Kim PY, Swystun LL, Liaw PC, Weitz JI. Activation of protein C and thrombin activable fibrinolysis inhibitor on cultured human endothelial cells. J Thromb Haemost. 2016; 14(2):366-374.","DOI":"10.1111\/jth.13222"},{"key":"72172","doi-asserted-by":"crossref","unstructured":"Duckers C, Simioni P, Spiezia L. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms. Blood. 2010; 115(4):879-886.","DOI":"10.1182\/blood-2009-08-237719"},{"key":"72173","doi-asserted-by":"crossref","unstructured":"Brogren H, Karlsson L, Andersson M, Wang L, Erlinge D, Jern S. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood. 2004; 104(13):3943-3948.","DOI":"10.1182\/blood-2004-04-1439"},{"key":"72174","doi-asserted-by":"crossref","unstructured":"Ohlin AK, Larsson K, Hansson M. Soluble thrombomodulin activity and soluble thrombomodulin antigen in plasma. J Thromb Haemost. 2005; 3(5):976-982.","DOI":"10.1111\/j.1538-7836.2005.01267.x"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285951\/77489","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285951\/78035","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11751\/77489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:14Z","timestamp":1794046034000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285951","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}